Paliperidone Tablet, Extended Release
Product Images NDC 72162-2649

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 72162-2649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622649)

Label (Lbl721622649)
This text appears to describe a medication called Paliperidone Extended-Release Tablets, each containing 3 mg of the active ingredient NDC 72162-2649-3. The tablets should be stored between 20°C to 25°C (68°F to 77°F), protected from moisture, and out of reach of children. They should be swallowed whole and not divided, crushed, or chewed. The package insert likely contains important prescribing information that can be accessed using a QR code on the packaging. The manufacturer is identified as ESKAYEF Pharmaceuticals, with relabeling done by Bryant Ranch Prepack, Inc.*
FDA Label Image

Chemical Structure (Paliperidone 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.